← Evidence map

ArticleOncology (Williston Park, N.Y.)2013

Ruxolitinib for myelofibrosis: from 'palliation' to prolongation of survival.

Srdan VerstovsekPubMed ↗Full text ↗

No numbers read from the abstract.

1 paper cites it

2013
2014
2015
2016
2017
2018
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23977769